Nodexus

About:

Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more.

Website: http://www.nodexus.com/

Twitter/X: NodexusInc

Top Investors: National Science Foundation, RA Capital Management, Section 32, SkyDeck Berkeley, Astia Angels

Description:

Nodexus is a Venture- and SBIR-backed biotech startup commercializing the NX One platform to address widespread unmet needs for accessible live single cell isolation in industrial/biopharma, clinical research, and academic sectors. The NX One platform consists of a low-infrastructure, low-cost hardware system and single-use disposable microfluidic cartridges tailored toward live single-cell workflows involving gene editing (e.g. CRISPR engineering), cell line/antibody development, and tumor heterogeneity studies.